Recombinant DNA Technology Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The report covers Recombinant DNA Technology Market Trends and the market is Segmented by Product (Medical (Therapeutic Agent, Human Protein, and Vaccine), and Non-medical (Biotech Crops, Specialty Chemicals, and Other Non-medical Products), Component (Expression System and Cloning Vector), Application (Food and Agriculture, Health and Disease, Environment, and Other Applications), End User (Biotechnology and Pharmaceutical Companies, Academic and Government Research Institutes, and Other End Users), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market provides the value (in USD million) for the above-mentioned segments.

Recombinant DNA Technology Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Recombinant DNA (rDNA) Technology Industry Overview

The Recombinant DNA (rDNA) Technology market is competitive, with the presence of both major players and small players. In terms of market share, the major players are currently dominating the market. Some of the major market players include GenScript, New England Biolabs, GlaxoSmithKline PLC, Pfizer, and Sanofi, among others.

Recombinant DNA (rDNA) Technology Market Leaders

  1. New England Biolabs

  2. GlaxoSmithKline plc

  3. Pfizer

  4. Sanofi

  5. GenScript

  6. *Disclaimer: Major Players sorted in no particular order
CL-RDTM.png

Recombinant DNA Technology Market Report Snapshots

80% of our clients seek made-to-order reports. How do you want us to tailor yours?